Parabilis Medicines, Inc. went public at $20.00 a share
It sold 33,500,000 shares under the ticker PBLS and raised $670.0 million before costs.
Final prospectus (424B4) filed June 10, 2026
The terms
-
Offered
33,500,000 shares
Checked
Source
“We are offering 33,500,000 shares of our common stock.”
A model read this, and code confirmed the quote appears in the filing. -
Price per share
$20.00
Checked
Source
“The initial public offering price per share is $20.00.”
A model read this, and code confirmed the quote appears in the filing. -
Raised
$670,000,000before fees and costs
Checked
Source and check
Shares × price = 33,500,000 × $20.00 = $670,000,000. They match.
“Initial public offering price | $20.00 | $670,000,000”
A model read this, and code confirmed the quote appears in the filing. -
Bank fee
$46,900,000$1.40 a share, 7.0% of the raise
Checked
Source
“Underwriting discounts and commissions (1) | $1.40 | $46,900,000”
A model read this, and code confirmed the quote appears in the filing. -
Company receives first
$623,100,000before other costs
Checked
Source and check
Raised − bank fee = $670,000,000 − $46,900,000 = $623,100,000. They match.
“Proceeds, before expenses, to Parabilis Medicines, Inc. | $18.60 | $623,100,000”
A model read this, and code confirmed the quote appears in the filing. -
Ticker
PBLS
Checked
Source
“Our common stock has been approved for listing on The Nasdaq Global Select Market under the symbol “PBLS”.”
A model read this, and code confirmed the quote appears in the filing. - Final prospectus filed June 10, 2026
Not investment advice.Open the filing on SEC.gov
Where the money goes first
The banks take their fee before the company sees the money.
Who owns the company after the IPO
From the prospectus 33,500,000 of 116,564,570 shares outstanding after the offering (28.7%).
Where Parabilis Medicines, Inc. sits among the last 12 months
Each bubble is one IPO. Bigger and higher means more money raised. The scale grows by ten times at each line.
New to these terms? How to read an IPO.